TTR and cardiac amyloidosis: Impact of disease-modifying therapy on [&lt;sup&gt;99m&lt;/sup&gt;Tc]Tc-DPD SPECT/CT markers in transthyretin cardiac amyloidosis enabled by artificial intelligence.